净重新分类改善与决策理论 - Suppr

Suppr

超能文献

Net reclassification improvement and decision theory.

作者信息

Vickers Andrew J, Elkin Elena B, Steyerberg Ewout

出版信息

Stat Med. 2009 Feb 1;28(3):525-6; author reply 526-8. doi: 10.1002/sim.3087.

DOI:10.1002/sim.3087

PMID:17907248

Abstract

摘要

相似文献

Net reclassification improvement and decision theory.净重新分类改善与决策理论

Stat Med. 2009 Feb 1;28(3):525-6; author reply 526-8. doi: 10.1002/sim.3087.

[Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].[鉴别能力、重新分类及净效益：生物标志物的预测价值]

Ned Tijdschr Geneeskd. 2012;156(41):A5029.

Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).对M. J. 彭西纳等人发表于《医学统计学》（DOI: 10.1002/sim.2929）的《评估新标志物的额外预测能力：从ROC曲线下面积到重新分类及其他》的评论

Stat Med. 2008 Jan 30;27(2):191-5. doi: 10.1002/sim.2987.

Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).对M. J. 彭西纳等人发表于《医学统计学》（DOI: 10.1002/sim.2929）上的“评估新标志物的额外预测能力：从ROC曲线下面积到重新分类及其他”一文的评论

Stat Med. 2008 Jan 30;27(2):185-7. doi: 10.1002/sim.2985.

The need for reorientation toward cost-effective prediction: comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).重新定位以实现具有成本效益的预测的必要性：对Pencina等人发表于《医学统计学》（DOI：10.1002/sim.2929）上的“评估新标志物的额外预测能力：从ROC曲线下面积到重新分类及其他”一文的评论

Stat Med. 2008 Jan 30;27(2):182-4. doi: 10.1002/sim.2986.

The need for reorientation toward cost-effective prediction: comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).重新定位以实现具有成本效益的预测的必要性：对M. J. 彭西纳等人发表于《医学统计学》（DOI: 10.1002/sim.2929）的《评估新标志物的额外预测能力：从ROC曲线下面积到重新分类及其他》的评论

Stat Med. 2008 Jan 30;27(2):199-206. doi: 10.1002/sim.2995.

Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929).对M. J. 彭奇纳、R. B. 达戈斯蒂诺 Sr、R. B. 达戈斯蒂诺 Jr、R. S. 瓦桑所著的《评估新标志物的额外预测能力：从ROC曲线下面积到重新分类及其他》的评论，发表于《医学统计学》（DOI: 10.1002/sim.2929）

Stat Med. 2008 Jan 30;27(2):188-90. doi: 10.1002/sim.2976.

Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination.有用的新危险因素的有用性测试：评估重新分类和区分的工具。

Scand J Public Health. 2011 Jun;39(4):439-41. doi: 10.1177/1403494810396556. Epub 2011 Jan 26.

Comments on 'Evaluating the added predictive ability of a new marker' by M. Pencina, R. D'Agostino, R. D'Agostino Jr, R. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929).对M. 彭奇纳、R. 达戈斯蒂诺、小R. 达戈斯蒂诺、R. 瓦桑所著《评估新标志物的额外预测能力》的评论，发表于《医学统计学》（DOI: 10.1002/sim.2929）

Stat Med. 2008 Jan 30;27(2):196-8. doi: 10.1002/sim.2948.

Editorial comment.编者按

J Urol. 2009 Nov;182(5):2121; discussion 2122. doi: 10.1016/j.juro.2009.07.151. Epub 2009 Sep 16.

引用本文的文献

Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention.多基因风险评分：癌症风险预测、筛查及精准预防的未来。

Med Rev (2021). 2022 Feb 14;1(2):129-149. doi: 10.1515/mr-2021-0025. eCollection 2021 Dec.

Multiple gene-specific DNA methylation in blood leukocytes and colorectal cancer risk: a case-control study in China.血液白细胞中多个基因特异性DNA甲基化与结直肠癌风险：一项中国的病例对照研究

Oncotarget. 2017 May 22;8(37):61239-61252. doi: 10.18632/oncotarget.18054. eCollection 2017 Sep 22.

Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.评价指标和风险预测模型：净重新分类指数与决策分析指标间关系概述。

Med Decis Making. 2013 May;33(4):490-501. doi: 10.1177/0272989X12470757. Epub 2013 Jan 11.

Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories.评估净重新分类改善在疾病预测中的应用：风险切点和风险分类数的影响。

Eur J Epidemiol. 2013 Jan;28(1):25-33. doi: 10.1007/s10654-012-9744-0. Epub 2012 Nov 20.

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.评估核基质蛋白 22 在监测阴性细胞学的非肌肉浸润性膀胱癌患者中的临床获益：决策曲线分析。

Cancer. 2011 Jul 1;117(13):2892-7. doi: 10.1002/cncr.25903. Epub 2011 Jan 10.

Performance of reclassification statistics in comparing risk prediction models.比较风险预测模型时重新分类统计的性能

Biom J. 2011 Mar;53(2):237-58. doi: 10.1002/bimj.201000078. Epub 2011 Feb 3.

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.将净重新分类改进计算扩展到测量新生物标志物的有用性。

Stat Med. 2011 Jan 15;30(1):11-21. doi: 10.1002/sim.4085. Epub 2010 Nov 5.

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.评估结合遗传和临床信息的乳腺癌风险模型的临床有效性。

J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27. doi: 10.1093/jnci/djq388. Epub 2010 Oct 18.

Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States.利用美国成年人的家族史信息提高对未确诊糖尿病的检测能力。

Am J Epidemiol. 2010 May 15;171(10):1079-89. doi: 10.1093/aje/kwq026. Epub 2010 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验